AACR 2 Virtual Meeting, 22–24 June 2020

An open-label, multi-cohort, phase Ib study of xentuzumab and abemaciclib: preliminary results from the advanced NSCLC cohort

Patricia LoRusso, Javier García-Corbacho, Fadi S. Braiteh, Anthony Gonçalves, Francesco Ricci, Hiroji Iwata, Marta Capelán, Marie-Paule Sablin, Aleix Prat, Molly Catherine Hardebeck, Marta Puig, Dennis Chin-Lun Huang, Mingchi Hsu, Douglas Yee

lorusso_1280.18_nsclc_aacr_poster
Methods
References

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

San Antonio Breast Cancer Symposium (SABCS​ 2019): A phase Ib multi-cohort study of xentuzumab and abemaciclib in patients with solid tumors and breast cancer – initial report of four
dose-finding cohorts

Douglas Yee, Mafalda Oliveira, Hiroji Iwata, Anthony Gonçalves, Javier García-Corbacho, Marie Paule Sablin, Aleix Prat, Molly Catherine Hardebeck, Marta Puig, Dennis Chin-Lun Huang, Mingchi Hsu, Patricia LoRusso

Yee et al_1280.18_SABCS 2019

FOR HEALTHCARE PROFESSIONALS ONLY

links_to_3rd_party.jpg